Drugs / TIV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00645411 Comparator | Oct 2007 → Feb 2008 | influenza | Novartis | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00645411 ↗ |
| Modality | Vaccine | “conventional egg-derived trivalent influenza vaccine (TIV)” PMID 22301476 ↗ May 2012 |